Healthcare Panorama
Healthcare has always been dominant to the global economy though in recent times it has assumed a vital role in the pathway to economic recovery. This in turn, can provide pressing opportunities to investors. Every fortnight, our team, guided by an expert on healthcare, scan the most opportune openings for investing in Healthcare IT, Hospitals/Providers, Medtech, Multilaterals, Pharma, Biotech and diagnostic sectors. Whether established or newbies, their main aim is to secure a low-risk high reward. This report can be a one stop solution for reflecting on views and insights, on particular stocks in the growing industry of Health sector.
Features
✓ Inclusive Daily Analysis Report to keep up with the latest on what's hot and what's not, Our analysts give their views on the recent market movements and developments, and what it all means.
✓ Buy, sell and Hold recommendations.
✓ Access to the past recommendations and past reports.
✓ Risk rating: Low to Medium Volatility
Report Frequency : Fortnightly
Publishing Time : 2nd and 4th Wednesday
Price
Price |
$1200 /
12 Months
(incl. of GST)
Our subscription comes with 14 days cooling-off period, however, it only applies to new subscribers.
We sell results, not just reports!
At Veye, we understand that making investment decisions can be a daunting task. That’s why we offer comprehensive market research on ASX stocks to help investors navigate the complexities of the market and make informed decisions about buying, selling or holding stocks. Our team of expert analysts conducts rigorous research and analysis to provide unbiased recommendations on a range of stocks across various industries. Our reports are designed to be accessible to all investors, regardless of their level of experience or financial expertise.
Subscribe NowFrequently Asked Questions
Past Recommendations
| Code | Avg Buy | Avg Sell | Gain/loss |
|---|---|---|---|
| Abacus Storage King (ASX: ASK) | $1.205 | $1.412 | +17.18% |
| Tamboran Resources Corporation (ASX: TBN) | $0.17 | $0.23 | +35.29% |
| Champion Iron Ltd (ASX: CIA) | $5.742 | $5.1293 | -10.67% |
| Emerald Resources NL (ASX: EMR) | $3.773 | $5.60 | +48.42% |
| Cynata Therapeutics Ltd (ASX: CYP) | $0.218 | $0.26 | +19.27% |
| Cynata Therapeutics Ltd (ASX: CYP) | $0.218 | $0.26 | +19.27% |
Disclaimer: Not every company performs as expected. Past performance is not an indication of future returns. “Gain/Loss” reflects movement in difference in average buy price and sell price plus dividends as a percentage of average buy price, and does not take into account costs or taxation.
